Shield managing director (MD) to retire
This article was originally published in Clinica
Executive Summary
Shield Diagnostics managing director Gordon Hall has announced his retirement, to take place immediately. This comes at an awkward time for the UK company, which is in negotiations for a licensing agreement for its AFT heart attack prediction test. Shares in the company fell 100p to 617.5p on the news.